Selected data models

You must log in to select data models for download or further analysis.

20 Search results.
Relevance Rating New first Old first

Eligibility Type 2 Diabetes Mellitus NCT02212951

- 4/15/20 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500; ODM derived from: https://clinicaltrials.gov/show/NCT02212951

Eligibility New Onset Diabetes Mellitus After Renal Transplantation NCT01268995

- 9/23/21 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT01268995

Eligibility Non-proliferative Diabetic Retinopathy NCT02062034

- 11/18/20 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy; ODM derived from: https://clinicaltrials.gov/show/NCT02062034

Screening Diabetes Mellitus-ASP1941-1941-CL-0004 NCT01071850

- 2/18/22 - 1 form, 18 itemgroups, 97 items, 1 language
Itemgroups: Cover Page, Informed Consent, Inclusion Criteria, Exclusion Criteria, Demographics, Primary Diagnosis, Subject Characteristics, Date of Visit, Tobacco History, Alcohol History, Urinary Tract Infection History, Genital Infection History, Physical Examination, Orthostatic vital signs, 12 Lead ECG 1, Height and Weight, Previous Diabetes Medication Use, Pregnancy Test
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes MellitusTEST Study Screening

Cumulative Diabetes Mellitus-ASP1941-1941-CL-0004 NCT01071850

- 9/28/16 - 1 form, 5 itemgroups, 60 items, 1 language
Itemgroups: Targeted Medical History, Medical History, Concomitant Medication, Adverse Events, Hospitalization Records
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes Mellitus Cumulative

Dosing Diabetes Mellitus-ASP1941-1941-CL-0004 NCT01071850

- 9/28/16 - 1 form, 5 itemgroups, 36 items, 1 language
Itemgroups: Study Drug: oral, Study Drug: Accountability - Kit 1, Study Drug: Accountability - Kit 2, Study Drug: Accountability - Kit 3, Study Drug: Accountability - Kit 4
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes Mellitus Dosing

Visit 9 Diabetes Mellitus-ASP1941-1941-CL-0004 NCT01071850

- 2/19/22 - 1 form, 10 itemgroups, 45 items, 1 language
Itemgroups: Date of Visit, Physical Examination, Orthostatic vital signs, 12 Lead ECG, Weight, Waist and Hip Circumference, Pregnancy Test, EQ-5D, ADDQol, Diab-MedSat
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes MellitusTEST Study Visit 9

Visit 8 Diabetes Mellitus-ASP1941-1941-CL-0004 NCT01071850

- 2/19/22 - 1 form, 8 itemgroups, 27 items, 1 language
Itemgroups: Date of Visit, Orthostatic Vital Signs, ECG: 12 Lead ECG 1, Weight, Waist and Hip Circumference, Pregnancy Test, Meal Data, Blood Sample
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes Mellitus Visit 8

Early Discontinuation Diabetes Mellitus-ASP1941-1941-CL-0004 NCT01071850

- 2/18/22 - 1 form, 10 itemgroups, 45 items, 1 language
Itemgroups: Date of Visit, Physical Examination, Orthostatic vital signs, 12 Lead ECG 1, Weight, Waist and Hip Circumference, Pregnancy Test, EQ-5D, ADDQol, Diab-MedSat
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes MellitusTEST Study Early Discontinuation

Visit 3 Diabetes Mellitus-ASP1941-1941-CL-0004 NCT01071850

- 2/17/22 - 1 form, 3 itemgroups, 11 items, 1 language
Itemgroups: Date of Visit, Orthostatic Vital Signs, Weight
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes MellitusTEST Study Visit 3

Visit 10 Diabetes Mellitus-ASP1941-1941-CL-0004 NCT01071850

- 2/16/22 - 1 form, 4 itemgroups, 13 items, 1 language
Itemgroups: Date of Visit, Orthostatic Vital Signs, Weight, Waist and Hip Circumference
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes MellitusTEST Study

Unscheduled Visit Diabetes Mellitus-ASP1941-1941-CL-0004 NCT01071850

- 9/28/16 - 1 form, 6 itemgroups, 28 items, 1 language
Itemgroups: Unscheduled Visit Checklist, Physical Examination, Orthostatic vital signs, 12 Lead ECG 1, Weight, Study Drug: Accountability - Unscheduled
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes Mellitus Unscheduled Visit

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial